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1. Introduction 
The functional state of the elongation-factor Tu 
from Eschetichia coli during the elongation cycle is 
controlled by guanine nucleotides (review [ 11). The 
differences in affinity of EF-Tu . GTP and EF-Tu . GDP 
towards aa-tRNAs, ribosomes and EF-Ts is considered 
to be due to conformational differences which depend 
on the guanine nucleotide that is bound to EF-Tu. A 
variety of experiments have been carried out that 
demonstrate conformational changes of EF-Tu upon 
substitution of GDP by GTP: hydrogen/tritium and 
hydrogen/deuterium exchange experiments [2,3], 
fluorescence spectroscopy employing reporter groups 
[4,5] as well as intrinsic tryptophane fluorescence [6], 
ESR [7,8] and proteolytic digestion [ 151. However, 
the optical rotatory dispersion spectra of EF-Tu . GDP 
and EF-Tu . GTP are identical [3,6]. This finding indi- 
cates that the conformational differences seen by other 
techniques must be rather subtle, since they do not 
lead to a change in the relative amount of secondary 
structure elements. The antibiotic kirromycin is known 
to inhibit protein biosynthesis by complex formation 
with EF-Tu and interfering with its various conforma- 
tional states [9-131. This effect could also be demon- 
strated by ESR and trypsin-induced cleavage experi- 
ments [14-161. 
The object of this study was to investigate the con- 
formations of EF-Tu f GDP and EF-Tu . GTP in absence 
and presence of kirromycin by ‘H NMR. ‘H NMR 
Abbreviations: NMR, nuclear magnetic resonance; ESR, elec- 
tron spin resonance;EF-Tu,elongation-factor Tu;SDS-PAGE, 
sodium dodecylsulphate-polyacrylamide gel electrophoresis 
DSS, 3-(trimethylsilyl)-propionic acid; HPLC, high pressure 
liquid chromatography; aa-tRNA, aminoacyl-transfer ribo- 
nucleic acid;M,, relative molecular mass 
ElsevierlNorth-Holland Biomedical Press 
spectra have so far only been obtained for EF-TU from 
Thermus thermophilus [17,18] or EF-Tu from E. coli 
complexed with tRNA [20], since EF-Tu from E. coli 
alone is unstable at room temperature. We have circum- 
vented the stability problem by doing all experiments 
at 1°C. The low field spectrum of EF-Tu shows several 
resolved exchangeable resonances in addition to the 
broad envelope of the CONH and aromatic resonances. 
Conversion of EF-Tu . GDP to EF-Tu . GTP leads to 
characteristic changes which in part can be simulated 
by addition of kirromycin to EF-Tu . GDP indicating, 
that indeed kirromycin makes EF-Tu . GDP more 
EF-Tu . GTP-like, as was suggested on the basis of 
kinetic investigations on the EF-Tu-guanine nucle- 
otide interaction [ 131 and of proteolytic digestion 
experiments [ 161. 
2. Materials and methods 
5’-GDP, 5’-GTP, phosphoenolpyruvate and pyruvate 
kinase were purchased from Boehringer (Mannheim). 
Kirromycin was prepared as in [lo]. EF-Tu was isolated 
from E. coli MRE 600 (Public Health Laboratory 
Service) exactly as in [ 191 with the modification that 
all buffers used during the purification contained 
0.1 PM GDP. After the AcA44 chromatography (LKB) 
fractions containing pure EF-Tu as judged by SDS- 
PAGE were loaded onto a DEAE-cellulose (Whatman 
DE-52) column (0.5 X 5 cm). The column was rinsed 
extensively with 0.05 M KC1 in buffer A (0.03 M 
K-phosphate (pH 7.2), 10 mM MgC12, 0.1 mM 1.4 dithi- 
oerytritol, 0.1 PM GDP). EF-Tu was subsequently 
eluted with 0.3 M KC1 in buffer A. The solution thus 
ohtained was -0.5-l .5 mM in EF-Tu. The concentra- 
tion of EF-Tu was determined using ez80 = 32900 
(,4t;onm = 7.6,M, 43 225). The nucleotide content 0 
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of EF-Tu was measured employing HPLC over a reverse- 
phase amino column (Riedel de Haen) with 0.7 M 
NH4H2P04 solution (pH 4.5) as elutant. Only those 
EF-Tu samples were used for further experiments that 
contained X.7 mol GDP/mol EF-Tu . GDP/GTP con- 
version was carried out in buffer A with a 2-fold excess 
of phosphoenolpyruvate, 25% the amount of GTP, 
both with respect to the EF-Tu concentration, and 
0.1 mg/ml pyruvate kinase, at 0°C for 30 min. Under 
these conditions 75-90% of EF-Tu . GDP was con- 
verted to EF-Tu . GTP depending on the EF-Tu sample. 
If kirromycin was present a higher excess of phospho- 
enolpyruvate was used in order to compensate for 
kirromycin-induced GTP hydrolysis. 
NMR spectra were accumulated at 1°C on a Bruker 
WH 270 instrument in correlation mode for 15-30 h 
and referenced downfield from DSS by use of water 
as secondary standard. For the broad exchangeable 
resonancesat he low field edge our sweep parameters, 
1800 Hz in 1 s, practically corresponded to a normal 
cw-scan. No deviations occurred after these peaks and 
the spectra could be plotted directly without correla- 
tion, reducing artificial oscillations at the sweep start 
otherwise produced by the correlation procedure from 
scans running close to the strong water signal. Spectra 
containing sharp lines, e.g., from free excess nucleo- 
tides, were correlated with the Bruker correlation pro- 
gram. Blank spectra of buffer were subtracted from the 
sample spectra in order to suppress baseline curvature 
and oscillation produced by the strong water signal. 
3. Results and discussion 
The ‘H NMR spectrum of EF-Tu . GDP in water 
shows several resolved peaks on the low field edge of 
the envelope of the exchangeable and aromatic reso- 
nances (fig.1). The resolved peaks easily exchange 
with D,O. Protein resonances have been postulated in 
this region on the basis of spectra of mixtures of EF-Tu 
and tRNAs [20]. 
3 .l . GDP/GTP conversion 
Upon conversion of GDP to GTP by addition of 
pyruvate kinase and phosphoenolpyruvate the lowest 
field peak is detected at somewhat higher fields and a 
characteristic difference spectrum appears at lo-14 
and -7.6 ppm (fig.2). It involves-S-10 protons when 
calibrated by the H8-resonance ofthe excess free GDP. 
After spontaneous hydrolysis of GTP which was 
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Fig.1. Low field ‘H NMR spectrum of EF-TLI GDP in H,O 
(--) and D,O (-,-): 1.3 mM EF-Tu ‘GDP, 5.8 mM phospho- 
enolpyruvate, 1.9 mM GDP, buffer A, 0.3 M KCl. 
PPm 
Fig.2. Low field ‘H NMR spectra of EF-Tu GDP (upper trace 
-) and EF-Tu GTP (upper trace ...,.) in H,O. Difference 
spectrum EF-Tu . GDP-EF-Tu GTP (middle trace). Control 
difference spectrum of the same sample before conversion of 
GDP to GTP (EF-Tu GDPinitial) and after hydrolysis of 
GTP to GDP (EF-TU GDPfinal) (lower trace) (cf. fig.3). 
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Fig.3. To a 1.3 mM EF-Tu GDP solution, which had been 
pm-incubated in buffer A, 0.3 M KC1 in the presence of 1 .V mM 
GDP and 5.8 mM phosphoenolpyruvate for 12 h at 1°C 
0.18 mg pyruvate kinase/ml was added. The solution was then 
incubated at 1°C. Aliquots (5 ~1) were withdrawn and analyzed 
by HPLC for its EF-Tu . GDP content: at 3-12 h nearly 80% 
of EF-Tu is present as EF-Tu GTP;after 30 h EF-Tu is present 
as EF-Tu GDP. NMR spectra were recorded in a parallel 
experiment during the preincubation, over 3--12 h and after 
30h. 
identical conditions (fig.3) the difference spectrum 
disappears again indicating that it has not been induced 
irreversibly by the pyruvate kinase. Control experi- 
ments also ruled out the possibility that the difference 
spectrum was produced by small pH changes upon 
nucleotide conversion. Preliminary experiments show 
that the resonances at 13.6 and 12.7 ppm are broadened 
by addition of 0.11 mM MnCla (fig.4). At the same 
Mn2+ levels the H8 and NH, peaks of free GDP are also 
broadened in our solution conditions. Since the only 
tight Mn2+ binding site of EF-Tu . GDP is associated 
with the nucleotide [8], we conclude that the exchange- 
able low field protons monitoring the conformation 
of EF-Tu . GDP and EF-Tu . GTP are in the vicinity 
of the nucleotide. Further assignment of these reso- 
nances is in progress. 
3.2. Effect of kirrornycin 
The lowest field peak of EF-Tu GDP and 
EF-Tu . GTP in the presence of kirromycin appears 
at the same position as for EF-Tu . GTP without kirro- 
mycin (fig.5) demonstrating that with respect to this 
Fig.5. LOW field ‘H NMR spectra of EF-Tu . GDP (upper 
trace -) and EF-Tu GTP (upper trace .....) in the presence 
of 1 .V mM kirromycin. Difference spectrum EF-TU GDP- 
EF-Tu . GTP (middle trace). Control difference spectrum 
EF-Tu GDPinitial-EF-Tu GDPfinal (lower trace) (cf. fig.2). 
EF-TU. GDP at 1 .l mM, 14 mM phosphoenolpyruvate,42 WM 
GDP, buffer A, 0.3 M KCl. 
2 
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Fig.4. Mn2+ dependence of the low field ‘H NMR spectrum 
of EF-Tu GDP. Reference spectrum without Mn” (upper 
trace). Difference spectra in the presence of 11 MM MnCl, 
minus reference spectrum (middle trace) and in the presence 
of 110 ,uM MnCl, minus reference spectrum (lower trace). 
EF-Tu at, 413 MM in buffer A, 0.3 M KCl. 
15 10 ' 
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resonance kirromycin can bring about a similar change 
as the conversion of GDP to GTP. At 11-l 3.5 and 
-7.6 ppm, however, kirromycin does not effect the 
difference spectrum EF-Tu . GDP/EF-Tu . GTP, indi- 
cating that the antibiotic cannot mimick all of the 
conformational changes which are due to the GDP/ 
GTP conversion. This is in agreement with ESR and 
water relaxation studies [ 141. It is tempting to specu- 
late, however, that the similar effect of kirromycin 
and GTP on the lowest field resonance is related to 
the inhibitory action of the antibiotic. This suggestion 
is confirmed by preliminary NMR results in the pres- 
ence of pulvomycin, which does not change the low 
field resonances of EF-Tu . GDP. Furthermore no 
changes of the low field spectrum are observed upon 
conversion of GDP to GTP in the presence of pulvo- 
mycin, indicating that the antibiotic freezes the 
EF-Tu . GDP conformation. The results support the 
idea that the function of the antibiotic is mediated by 
conformational changes of EF-Tu: kirromycin stabi- 
lizes a conformation of EF-Tu which is similar to the 
one of EF-Tu GTP, regardless of which nucleotide 
is bound to the factor. Pulvomycin,however,stabilizes 
a conformation which is similar to the one of 
EF-Tu . GDP, again regardless of which nucleotide is 
bound. 
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